Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)

NCT02739997 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Intra-abdominal Infection
Complicated Intra-abdominal Infection

Interventions

DRUG: MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g)
DRUG: metronidazole 500 mg

Sponsor

Merck Sharp & Dohme LLC